Published in Neurogastroenterol Motil on March 27, 2013
Hiatus Hernia as a Cause of Dysphagia. Curr Gastroenterol Rep (2017) 0.75
Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography. Neurogastroenterol Motil (2012) 7.24
The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil (2014) 4.69
Increasing incidence of Barrett's oesophagus in the general population. Gut (2005) 2.34
Effects of anti-reflux surgery on weakly acidic reflux and belching. Gut (2010) 2.25
Port site metastases after laparoscopic colorectal surgery for cure of malignancy. Br J Surg (1995) 2.12
Subcutaneous metastases after laparoscopic colectomy. Lancet (1994) 2.11
Diagnostic value of the proton pump inhibitor test for gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther (2006) 2.07
[Acute dysphasia: often there is a readily treatable cause]. Ned Tijdschr Geneeskd (2003) 2.03
Esophageal acid exposure decreases intraluminal baseline impedance levels. Am J Gastroenterol (2011) 1.91
Systematic review and meta-analysis of laparoscopic Nissen (posterior total) versus Toupet (posterior partial) fundoplication for gastro-oesophageal reflux disease. Br J Surg (2010) 1.85
Systematic review: temporary stent placement for benign rupture or anastomotic leak of the oesophagus. Aliment Pharmacol Ther (2011) 1.85
PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis. Neurogastroenterol Motil (2012) 1.80
Determinants of perception of heartburn and regurgitation. Gut (2005) 1.69
Staging investigations for oesophageal cancer: a meta-analysis. Br J Cancer (2008) 1.69
Admission time is associated with outcome of upper gastrointestinal bleeding: results of a multicentre prospective cohort study. Aliment Pharmacol Ther (2012) 1.63
Cardiovascular and gastrointestinal outcomes in clopidogrel users on proton pump inhibitors: results of a large Dutch cohort study. Am J Gastroenterol (2010) 1.58
Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity. Rotterdam Oesophageal Tumour Study Group. Br J Surg (1999) 1.56
Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia. Aliment Pharmacol Ther (2012) 1.53
Risk of primary sclerosing cholangitis is associated with nonsmoking behavior. Gastroenterology (1996) 1.48
[Palliative treatment of esophageal cancer with dysphagia: more favourable outcome from single-dose internal brachytherapy than from the placement of a self-expanding stent; a multicenter randomised study]. Ned Tijdschr Geneeskd (2005) 1.48
Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. Histopathology (2007) 1.47
Objective definition and detection of transient lower esophageal sphincter relaxation revisited: is there room for improvement? Neurogastroenterol Motil (2011) 1.46
Prediction scores in gastrointestinal bleeding: a systematic review and quantitative appraisal. Endoscopy (2012) 1.45
Endoscopic ablation therapy for Barrett's esophagus with high-grade dysplasia: a review. Am J Gastroenterol (1999) 1.45
Aerophagia, gastric, and supragastric belching: a study using intraluminal electrical impedance monitoring. Gut (2004) 1.43
Evaluation of reporting based on descriptional knowledge. J Am Med Inform Assoc (1996) 1.42
Predictors of objectively identified recurrent reflux after primary Nissen fundoplication. Br J Surg (2011) 1.42
[Diagnosis and treatment of esophageal cancer in the Netherlands: wide variation in the second line]. Ned Tijdschr Geneeskd (2003) 1.40
Factors influencing the miss rate of polyps in a back-to-back colonoscopy study. Endoscopy (2012) 1.39
[Therapy-resistant gastro-oesophageal reflux disease: endoluminal treatment not yet sufficiently compared with the gold standard, the laparoscopic Nissen fundoplication]. Ned Tijdschr Geneeskd (2008) 1.38
[Gastrojejunostomy versus endoscopic stent placement as palliative treatment of malignant stenosis of the duodenum: overview of advantages and disadvantages on the basis of a literature study]. Ned Tijdschr Geneeskd (2007) 1.38
5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial. Gut (2004) 1.37
Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study. Am J Gastroenterol (2011) 1.36
Prevalence of delayed gastric emptying in diabetic patients and relationship to dyspeptic symptoms: a prospective study in unselected diabetic patients. Diabetes Care (2003) 1.34
Symptom association analysis in ambulatory gastro-oesophageal reflux monitoring. Gut (2005) 1.29
Endoscopic gastroplication for the treatment of gastro-oesophageal reflux disease: a randomised, sham-controlled trial. Gut (2006) 1.28
Normal values for solid-state esophageal high-resolution manometry in a European population; an overview of all current metrics. Neurogastroenterol Motil (2014) 1.24
Rapidly increasing incidence of eosinophilic esophagitis in a large cohort. Neurogastroenterol Motil (2012) 1.22
Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy. Br J Cancer (2003) 1.22
Persistence and adherence to proton pump inhibitors in daily clinical practice. Aliment Pharmacol Ther (2006) 1.18
Adherence to gastroprotection and the risk of NSAID-related upper gastrointestinal ulcers and haemorrhage. Aliment Pharmacol Ther (2007) 1.17
Oesophageal cancer incidence and mortality in patients with long-segment Barrett's oesophagus after a mean follow-up of 12.7 years. Scand J Gastroenterol (2004) 1.17
Endoscopic retroperitoneal adrenalectomy: lessons learned from 111 consecutive cases. Ann Surg (2000) 1.16
Stent-in-stent technique for removal of embedded esophageal self-expanding metal stents. Am J Gastroenterol (2010) 1.16
Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study. Br J Cancer (2006) 1.14
5-Aminolaevulinic acid-induced protoporphyrin IX accumulation in tissues: pharmacokinetics after oral or intravenous administration. J Photochem Photobiol B (1998) 1.14
The burden of upper gastrointestinal endoscopy in patients with Barrett's esophagus. Endoscopy (2006) 1.13
Benign anastomotic strictures after transhiatal esophagectomy and cervical esophagogastrostomy: risk factors and management. J Thorac Cardiovasc Surg (1996) 1.13
The homeodomain protein CDX2 is an early marker of Barrett's oesophagus. J Clin Pathol (2004) 1.12
Retroperitoneal endoscopic ligation of lumbar and inferior mesenteric arteries as a treatment of persistent endoleak after endoluminal aortic aneurysm repair. J Vasc Surg (2000) 1.11
Gastrojejunostomy versus stent placement in patients with malignant gastric outlet obstruction: a comparison in 95 patients. J Surg Oncol (2007) 1.10
Disease burden of post-infectious irritable bowel syndrome in The Netherlands. Epidemiol Infect (2010) 1.09
Review article: the clinical relevance of transient lower oesophageal sphincter relaxations in gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2011) 1.09
Birch pollen sensitization with cross-reactivity to food allergens predominates in adults with eosinophilic esophagitis. Allergy (2013) 1.09
Safety and efficacy of a new non-foreshortening nitinol stent in malignant gastric outlet obstruction (DUONITI study): a prospective, multicenter study. Endoscopy (2011) 1.05
Port-site metastases. Impact of local tissue trauma and gas leakage. Surg Endosc (1998) 1.05
Assessment of oesophageal motor function using combined perfusion manometry and multi-channel intra-luminal impedance measurement in normal subjects. Neurogastroenterol Motil (2005) 1.05
Variety in vegetable and fruit consumption and the risk of gastric and esophageal cancer in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2012) 1.05
The effects of the specific 5HT(4) receptor agonist, prucalopride, on colonic motility in healthy volunteers. Aliment Pharmacol Ther (2002) 1.04
Reproducibility of esophageal high-resolution manometry. Neurogastroenterol Motil (2011) 1.04
Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: a study in patients with (pre)malignant lesions of the oesophagus. Br J Cancer (1998) 1.03
Normal values for esophageal high-resolution manometry. Neurogastroenterol Motil (2013) 1.02
Detection of distant metastases in patients with oesophageal or gastric cardia cancer: a diagnostic decision analysis. Br J Cancer (2007) 1.00
Elicitation of transient lower oesophageal sphincter relaxations in response to gastric distension and meal ingestion. Neurogastroenterol Motil (2002) 1.00
Glycemic index, glycemic load, dietary carbohydrate, and dietary fiber intake and risk of liver and biliary tract cancers in Western Europeans. Ann Oncol (2012) 1.00
Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer. Br J Cancer (2002) 0.99
The effect of baclofen on gastro-oesophageal reflux, lower oesophageal sphincter function and reflux symptoms in patients with reflux disease. Aliment Pharmacol Ther (2002) 0.99
Causes and treatment of recurrent dysphagia after self-expanding metal stent placement for palliation of esophageal carcinoma. Endoscopy (2004) 0.99
Endoscopic ultrasound-guided ethanol ablation of a symptomatic sporadic insulinoma. Endoscopy (2011) 0.99
A pro-inflammatory genotype predisposes to Barrett's esophagus. Carcinogenesis (2008) 0.98
Single and sequential biodegradable stent placement for refractory benign esophageal strictures: a prospective follow-up study. Endoscopy (2012) 0.98
Double-peaked high-pressure zone at the esophagogastric junction in controls and in patients with a hiatal hernia: a study using high-resolution manometry. Dig Dis Sci (2004) 0.98
Revision of failed laparoscopic adjustable gastric banding to Roux-en-Y gastric bypass. Obes Surg (2006) 0.97
Effects of adjustable gastric banding on gastroesophageal reflux and esophageal motility: a systematic review. Obes Rev (2009) 0.96
Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Br J Cancer (2009) 0.96
Systematic review: the effects of conservative and surgical treatment for obesity on gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2009) 0.95
Gastroesophageal reflux disease is associated with the C825T polymorphism in the G-protein beta3 subunit gene (GNB3). Am J Gastroenterol (2009) 0.95
Colorectal visceral perception in diverticular disease. Gut (2004) 0.95
Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort. Br J Cancer (2012) 0.95
Laparoscopic Nissen fundoplication after failed EsophyX fundoplication. Br J Surg (2010) 0.95
Normative values in esophageal high-resolution manometry. Neurogastroenterol Motil (2014) 0.94
Expandable stents for malignant esophageal disease. Gastrointest Endosc Clin N Am (2011) 0.94
Long-term effect of fundoplication on motility of the oesophagus and oesophagogastric junction. Br J Surg (2004) 0.94
Cost comparison of gastrojejunostomy versus duodenal stent placement for malignant gastric outlet obstruction. J Gastroenterol (2009) 0.94
Oesophagitis is common in patients with achalasia after pneumatic dilatation. Aliment Pharmacol Ther (2006) 0.94
Hepatic and peripheral insulin sensitivity do not improve 2 weeks after bariatric surgery. Obesity (Silver Spring) (2013) 0.93
Abnormalities of left colonic motility in ambulant nonconstipated patients with irritable bowel syndrome. Dig Dis Sci (2003) 0.93
Assessment of oesophageal emptying in achalasia patients by intraluminal impedance monitoring. Neurogastroenterol Motil (2006) 0.92
The role of socio-economic status in the decision making on diagnosis and treatment of oesophageal cancer in The Netherlands. Br J Cancer (2006) 0.92
How often is large smaller than small? Lancet (1995) 0.92
First data on the Evolution duodenal stent for palliation of malignant gastric outlet obstruction (DUOLUTION study): a prospective multicenter study. Endoscopy (2013) 0.91
High-resolution manometry. Dig Liver Dis (2007) 0.91
Sensation of stasis is poorly correlated with impaired esophageal bolus transport. Neurogastroenterol Motil (2013) 0.91
Effects of ursodeoxycholic acid therapy on in vitro gallbladder contractility in patients with cholesterol gallstones. Dig Dis Sci (1999) 0.91
Relationship between esophageal contraction patterns and clearance of swallowed liquid and solid boluses in healthy controls and patients with dysphagia. Neurogastroenterol Motil (2012) 0.90